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Abstract
The rabies Flury Low Egg Passage virus (LEP) has been widely used as a seed virus to generate inactive vaccine.
Here, we established a reverse genetic system for LEP and generated a recombinant LEP virus (rLEP-G) that carries
two identical G genes. This recombinant virus showed similar properties to those of LEP with respect to in vitro
growth, neurotropism index, and virulence in mice. rLEP-G produced 4.3-fold more G protein than did LEP in BHK-
21 cells. The inactivated vaccine generated from rLEP-G induced significantly higher virus neutralization titers in
mice and dogs than those produced in response to LEP-derived vaccine. Our results suggest that rLEP-G is an
improved seed virus candidate for inactivated rabies virus vaccine manufacture.
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Introduction
Rabies virus (RV) belongs to the genus Lyssavirus of the
family Rhabdoviridae, and causes a fatal neurological
disease in humans and animals [1] More than 55,000
people die of rabies each year, and about 95% of these
deaths occur in Asia and Africa [2]. An estimated
31,000 people die from dog rabies in Asia each year,
with most cases occurring in India and China [3,4]. The
most cost-effective strategy for preventing rabies in peo-
ple is to eliminate rabies in dogs via vaccination [5-7]
Inactivated rabies vaccine has been shown to be a safe
and efficient means to control rabies in dogs. However,
the vaccination rate of dogs in many developing coun-
tries is low, especially in rural areas, mainly due to low
economic development and the high cost of vaccination
[8] More efficient and lower cost inactivated vaccine is,
therefore, still needed.
The surface glycoprotein (G) of RV is the major anti-
gen responsible for the induction of protective immunity
[1] Increasing G protein levels should, therefore,
enhance the protective viral neutralization antibody
(VNA) response. The rabies Flury low egg passage virus
(LEP) has been widely used as a seed virus to generate
inactive vaccine for humans and animals because of its
high immunogenicity and high growth titer in cell cul-
ture [9]. Here, we generated a recombinant LEP virus
that carries two identical G genes to increase G protein
expression. Growth curves, neurotropism index, viru-
lence, and the G protein expression level of the double-
G LEP were tested in vitro and in vivo.T h ei m m u n o -
genicity of the inactivated vaccine derived from this
double-G LEP was also evaluated in mice and dogs and
compared with that of LEP.
Materials and Methods
Viruses and cells
Neuroblastoma (NA) cells of A/J mouse origin were
grown in Eagle’s minimum essential medium (MEM)
supplemented with 10% fetal bovine serum (FBS). Baby
hamster kidney (BHK-21) cells were grown in
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ted with 10% FBS. The RV LEP (AV2012) was obtained
from the China Veterinary Culture Collection Center
and propagated in BHK-21 cells. A street virus, GX/09,
w a si s o l a t e df r o mt h eb r a i no fad o gt h a td i e do fr a b i e s
and was propagated in the brain of adult mice. All
viruses were kept in at -70°C before use.
Plasmids construction
Viral RNA was extracted with an RNeasy mini kit
according to the manufacturer’s instructions (QIAGEN,
Valencia, CA). The extracted RNA was subjected to RT-
PCR with virus specific primer pairs (Table 1) and high-
fidelity Pfx DNA polymerase (Invitrogen Corp., Carls-
bad, CA) to generate three overlapping PCR fragments
(F1, F2, and F3) that encompassed the entire viral gen-
ome. The assembled cDNA, containing the hammerhead
ribozyme sequence (HamRz), the full-length (11,925-
nucleotide) cDNA of the LEP strain genome in the anti-
genomic orientation, and the hepatitis delta virus ribo-
zyme sequence (HdvRz), was inserted between the Nhe I
and Sma Is i t e so fp C I .APme I restriction site was
introduced into the G-L noncoding region by changing
three nucleotide residues at positions 4907 (T to G),
4910 (G to T) and 4912 (C to A) by using a site-direc-
ted mutagenesis system (Invitrogen) with the primers
shown in Table 1. The resultant plasmid was designated
as pLEP. The cDNA of 1,801 nucleotides including the
open reading frame of the G gene was amplified from
pLEP by the primer pair shown in Table 1. The frag-
ment was introduced into the LEP genome through the
Pme I site. The resultant plasmid was designated as
pLEP-G (Figure 1). The open reading frames (ORFs) of
the N, P, and L genes were PCR-amplified from pLEP-G
with the primers shown in Table 1 for the construction
of the N, P, and L expression plasmids. The amplified
N, P, and L genes were inserted between the EcoR I and
Kpn I sites in the plasmid pCAGGS and were designated
as pCA-N, pCA-P, and pCA-L, respectively. The
assembled full-length cDNA clone and the helper plas-
mids were sequenced in their entirety to ensure that no
undesirable mutations had been introduced.
Virus rescue
BHK-21 cells were grown overnight to 80% confluence
in 6-well plates in DMEM supplemented with 10% FBS.
Cells were transfected with 4.0 μg of the full-length
plasmid pLEP-G, 2 μgo fp C A - N ,1μg of pCA-P, and 1
μgo fp C A - Lb yu s i n gL i p o f e c t a m i n e ™ 2000 (Invitro-
gen) according to the manufacturer’s protocol. After 4-6
h, the transfection medium was replaced with fresh
medium. After 3 days, supernatants were transferred
onto BHK-21cells and incubated for a further 3 days.
Rescued viruses were examined by using an indirect
fluorescence assay (IFA) with mouse anti-RV serum and
FITC-conjugated goat anti-mouse IgG (Sigma). Superna-
tants from virus-positive cultures were collected to pro-
pagate virus stocks in BHK-21 cells. Sequences of
recovered viruses were confirmed by sequencing entire
viral genomes. To confirm whether the recovered rabies
virus was derived from the cloned pLEP-G, RT-PCR was
performed with the primers shown in Table 1, positive-
sense G4 and negative-sense G3 primers at nucleotide
positions 4,302 to 4,321 and 3,613 to 3,632 (based on
the genomic nucleotide number of the LEP strain),
respectively. The fragment was further digested with
Pme I, and the supernatants from virus-positive cultures
were used to produce virus stocks in BHK-21 cells. The
rescued virus generated from the full-length plasmid
pLEP-G was designated as rLEP-G.
Multistep growth assays
Confluent BHK-21 or NA cell monolayers grown in 6-
well plates were infected with LEP or rLEP-G at a multi-
plicity of infection (MOI) of 0.01. After incubation for 1
h at 37°C, the inoculums were removed and the cells
were washed twice with PBS. BHK-21 and NA cells
were replenished with DMEM containing 2% FBS or
with MEM containing 0.2% FBS, respectively, and incu-
bated at 37°C. Culture supernatant (100 μl) was har-
vested at 0, 1, 2, 3, 4, and 5 days post-inoculation for
virus titration.
Virus titration
Monolayers of NA or BHK-21 cells in 24-well plates
were infected with 10-fold dilutions of virus suspension
and incubated at 37°C. At 48 h post-infection, an IFA
test was performed. Foci were counted under a fluores-
cence microscope and calculated as focus forming unit/
ml (FFU/ml).
The in vitro neurotropism index was expressed as the
logarithm of the titer of virus stock in NA cells minus
t h el o g a r i t h mo ft h et i t e ro ft h es a m es t o c ki nB H K - 2 1
cells [10]. The virus titers for neurotropism index calcu-
lation were based on the titration results of virus stock
harvested at 72 h post infection.
Western blotting
BHK-21 cells grown in 6-well plates were infected with
LEP or rLEP-G at an MOI of 1 and incubated for 48 h.
G gene expression was confirmed by using western blot-
ting as described previously [11]. Briefly, cell extracts
were subjected to 10% polyacrylamide gel electrophor-
esis (SDS-PAGE), and then blotted to nitrocellulose
membrane. The membrane was incubated with a mix-
ture of mouse anti-G protein polyclonal antiserum and
anti-b-actin monoclonal antibody (Santa Cruz Biotech-
nology), as the first antibody, and then with IRDye700-
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Page 2 of 7Table 1 Primers used to construct the full-length cDNA clone and helper plasmids for Flury LEP
Purpose Name Primer (5’-3’)
a
For F1 amplification F1-F
TGCGCTAGCTGTTAAGCGTCTGATGAGTCCGTGAGGACGAAACTATAGGAAAGGAATTCCTATAGTCACGCTTAACAACAAAACCAAAGAA
b
F1-R GGCACGCGTACTCCACATAACTTGAGTTTGC
For F2 amplification F2-F
AGGCCTGTATAAGTCTTTAAAGGGAGCA
F2-R ATCGGGGTTCCCGGCCTCTTGACACAAC
For F3 amplification F3-F
TATGCTAGCTCTGGTTAAGCTCCCACGAATC
F3-R CGATCCCGGGccccgcgggggcccctcccttagccatccgagtggacgaacgtcctccttcggatgcccaggtcggaccgcgaggaggtggagatgccatgccgacccACGCTTAACAAATAAACAAT
c
For Pme I
mutation
Pmu-F GACTTGAAGTTTAAACAGGATGACCGGCC
d
Pmu-R GGCCGGTCATCCTGTTTAAACTTCAAGTC
For G
gene
amplification G1
ATGCGTTTAAACAAGTTTATCACTTGTTTACCTCT
G2 GCATGTTTAAACACTTGAAGTGTCAAAAGGATGA
For N
gene
amplification HN-F
GGCGAATTCATGGATGCCGACAAGATTGT
HN-R CCGGGTACCTTATGAGTCACTCGAATACG
For L gene amplification HL-F
GGCGAATTCATGCTGGATCCGGGAGAGGTTT
HL-R CCGGGTACCTTACAAACAACTGTAGTCTA
For LEP-G confirmation G3
ATGCTTTCTCTTGAATGTGG
G4 GGGTTTGGAAAAGCATATAC
a Restriction enzyme sites are shown in boldface.
b The HamRz sequence is shown in italics.
c The HdvRz sequence is shown in lowercase.
d The nucleotides that were changed are underlined.
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7conjugated anti-mouse IgG (Rockland, Gilbertsville, PA)
as the second antibody. The mouse anti-G protein poly-
clonal antiserum was generated by immunization with a
recombinant Newcastle disease virus that expresses the
RV glycoprotein and was developed in our lab. Signal
intensities were analyzed by using the Odyssey infrared
image system (LiCor). The densitometry of each band
was quantified with Photoshop CS2. The G/b-actin ratio
was calculated by dividing the densitometry of the G
protein band by that of the b-actin protein band.
Infection of mice
The virulence of LEP and rLEP-G for adult mice was
measured in 6-week-old female Balb/c mice (Vital River,
Beijing). To determine the 50% lethal dose (LD50)o f
each virus, groups of five adult mice were inoculated
intracerebrally (i.c.) with 30 μlo ri n t r a m u s c u l a r l y( i.m.)
with 100 μl of serial 10-fold dilutions of LEP or rLEP-G.
After infection, mice were observed for 21 days for clini-
cal signs or death. The LD50 of each virus was calcu-
lated by using the method of Reed and Muench [12].
Preparation of inactivated vaccines
B H K - 2 1c e l l sg r o w ni n7 5c m
2 flask were infected with
LEP or rLEP-G at an MOI of 0.01 and incubated at 37°
C. At 96 h post-infection, cells were suspended in the
supernatant by using a rubber policeman. The suspen-
sion was submitted to three cycles of freezing and thaw-
ing (-20°C/37°C, 5 min each) and then subjected to
ultrasonic sound to increase the cell extraction dissolu-
tion. After centrifuge, supernatants were collected and
stored in -70°C. The infectious viruses in the
supernatant were titrated in BHK cells. To prepare inac-
tivated vaccines, the supernatant was incubated at 37°C
for 2 h in the presence of 0.03% b-propiolactone. Then,
three volumes of inactivated supernatant preparation
(non-dilution, 20-f old dilution, and 80-fold dilution)
were mixed with one volume of Rehydraphos AlPO4
adjuvant (Reheis, Berkeley Heights, NJ), and stored at 4°
C for vaccination.
Immunization of Balb/c mice and dogs
Groups of ten 4-week-old female Balb/c mice were
inoculated i.m. in the gastrocnemius muscle with 100 μl
of 20- or 80-fold dilutions of inactivated vaccine pre-
parations. Groups of six 3-month-old Beagles were
inoculated i.m. with 1 ml of inactivated vaccine
preparations.
VNA assay
Three weeks after immunization, mice were bled from
the retro-orbital sinus under isoflurane inhalation
anesthesia and Beagles were bled from the vein of the
f r o n tl e g .S e r aw e r et e s t e df o rn e u t r a l i z i n ga n t i b o d i e s
(VNA) by using the rapid fluorescent focus inhibition
test (RFFIT) [13]. Neutralization titers, defined as the
highest serum dilution that neutralizes 50% of the chal-
lenge virus, were normalized to international units (IU)
according to the World Health Organization anti-RV
antibody standard.
Results
Recovery of rLEP-G from cloned cDNA
The full-length genome plasmids of recombinant LEP
carrying two identical G genes were assembled and used
to rescue recombinant virus. The resulting virus was
designated as rLEP-G. To exclude the possibility of con-
tamination with LEP, a cDNA fragment covering the G-
G noncoding region was amplified from the genomic
RNA of the rescued recombinant virus and LEP, respec-
tively, by using RT-PCR with a set of primers, G3 and
G4. The amplified cDNA fragments were digested with
Pme I. A fragment with the expected size of 1,125 bp
was amplified from the genomic RNA of rLEP-G,
whereas RT-PCR with the genomic RNA of LEP did not
amplify any detectable product (Figure 2A). The ampli-
fied cDNA fragment was digested with Pme I, and 610-
bp and 515-bp bands were observed (Figure 2B).
Sequence analysis further confirmed that the virus was
rescued from cloned pLEP-G. RV G protein expression
by rLEP-G in BHK-21 cells was compared with that of
LEP by using Western blot analysis. G protein was
expressed at a significantly higher level in rLEP-G-
infected cells than in LEP-infected cells (Figure 2C). In
LEP-infected cells, the G/b-actin ratio was 1.2, whereas
in rLEP-G-infected cells the G/b-actin ratio was 5.1,
N    P    M       G          G                      L            
N      P   M        G                      L                     
Pme I
pLEP
pLEP-G
G1 G2
Pme I  digestion
HamRz HdvRz
Figure 1 Schematic representation of recombinant virus
containing two homologous G genes. The pLEP vector was
obtained by assembling three overlapping cDNA fragments of the
Flury LEP strain into the vector pCI, as described in the Methods.
The 1801-bp fragment including the G gene ORF was introduced
into the LEP genome through the Pme I site in the G-L noncoding
region. The hammerhead ribozyme sequence (HamRz) was
introduced upstream of the LEP genome, and the hepatitis delta
virus ribozyme sequence (HdvRz) was introduced downstream of
the viral genome.
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levels in rLEP-G-infected cells due to expression from
the additional G gene.
Growth properties of rLEP-G in vitro
To examine whether insertion an identical G gene into
the genome of the LEP strain would affect the growth
properties of the virus in vitro, we compared the growth
of rLEP-G and LEP in both neuronal NA cells and non-
neuronal BHK-21 cells. The multistep growth curves of
rLEP-G (the third passage generation from BHK-21
cells) were compared with that of LEP in NA cells.
There were no significant differences in growth patterns
in both cell lines (Figure 3A, B) between rLEP-G and
LEP. Furthermore, LEP and rLEP-G showed similar in
vitro neurotropism indices of 0.84 and 0.85, respectively,
which indicates that the additional G gene did not affect
the in vitro neurotropism of the LEP strain.
To examine the genome stability of rLEP-G in cell
culture, the virus was serially passaged in BHK-21 cells
10 times. RT-PCR analysis revealed that the additional
G gene in the rLEP-G genome was stable for at least 10
p a s s a g e si nB H K - 2 1c e l l s .T h et i t e ro fr L E P - Ga l s o
remained high at approximately 1 × 10
8 FFU/ml, from
the third to the tenth passage (Figure 4).
Pathogenicity of rLEP-G in adult mice
The G protein plays an important role in the pathogeni-
city of RV. Therefore, we needed to investigate whether
insertion of an additional G gene would affect virulence.
Accordingly, adult mice were inoculated with rLEP-G
and LEP, respectively. The results showed that both
rLEP-G and LEP caused neurological symptoms, such as
paralysis and hyperactivity, and killed mice after i.c.
inoculation. The LD50 of rLEP-G following i.c. inocula-
tion was 2 FFU, which was 2-fold higher than that of
LEP (Figure 5). Peripheral pathogenicity was also exam-
ined following i.m. inoculation. All mice survived i.m.
inoculation with 10
6 FFU of rLEP-G, whereas, one of
the five mice inoculated i.m. with the same dose of LEP
died. This result indicates that the in vivo neuro-inva-
siveness and peripheral pathogenicity of LEP did not
increase after insertion of the additional G gene.
Induction of VNA in mice and dogs
VNA is mainly induced by viral antigen G protein and
p l a y sak e yr o l ei ni m m u n ep r o t e c t i o nf r o mr a b i e s .T o
investigate whether increased expression of G in the seed
virus improves the VNA response of inactivated rabies
vaccine, two inactivated vaccines were respectively pre-
parations from LEP and rLEP-G infected cell cultures as
described in materials and methods. The virus titers in
supernatant of LEP and rLEP-G infected cell cultures were
10
7.4 FFU/ml and 10
7.3 FFU/ml respectively. The prepara-
tions were then tested in adult mice by using i.m.
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cells. BHK-21 cells were infected with rLEP-G at an MOI of 0.01. The
infected cell culture supernatants from each passage were
harvested at 96 h post-inoculation, and virus titers were determined
in triplicate in BHK-21 cells.
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Figure 2 Confirmation of recovery of the rLEP-G from cloned
cDNA. (A) RT-PCR, with the G3 and G4 primers, detected the
genome RNA from rLEP-G after two passages in BHK-21 cells (lane
1), LEP (lane 2), and rLEP-G after 10 passages in BHK-21 cells (lane
3). (B) The RT-PCR amplified cDNA fragment was digested with Pme
I. M, molecular weight marker. (C) Western blot analysis of G protein
expression in BHK-21 cells infected with viruses. Cells were collected
at 96 h post-infection with LEP or rLEP-G and subjected to Western
blot analysis as described in the Methods. The G/b-actin ratio was
calculated by dividing the densitometry of the G protein band by
that of the b-actin protein band.
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Figure 3 Multistep growth curves for LEP and rLEP-G. NA cells
(A) and BHK-21 Cells (B) were infected at an MOI of 0.01. The
infected cell culture supernatants were harvested at different time
post-inoculation, and virus titers were determined in triplicate in
BHK-21 cells.
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Page 5 of 7inoculation with. There were no significant differences in
VNA response between the mice that received 0.1 ml of
20-fold diluted LEP vaccine preparation (containing 5.2
log10 FFU/0.1 ml) and those that received 0.1 ml of 20-
fold diluted LEP-G vaccine preparation (for LEP and 5.1
log10 FFU/0.1 ml for rLEP-G). However, the VNA of mice
immunized with an 80-fold diluted rLEP-G vaccine pre-
paration (containing 4.5 log10 FFU/0.1 ml) was signifi-
cantly higher than that of mice immunized with a
similarly diluted LEP vaccine preparation (containing 4.4
log10 FFU/0.1 ml) (P < 0.01) (Figure 6A). In dogs, 1 ml of
rLEP-G vaccine preparation (containing 7.3 log10 FFU/ml)
induced a VNA mean titer of 54 IU, which was signifi-
cantly higher than mean titer of 15 IU that induced by 1
ml of LEP inactivated vaccine (containing 7.2 log10 FFU/
ml) (P < 0.05) (Figure 6B). These results indicate that the
rLEP-G strain is a more immunogenic seed virus for use
in the development of inactive vaccines against rabies.
Discussion
Mass vaccination of dogs has proven to be an effective
way to control rabies in this species. However, current
live attenuated vaccines can have safety issues [14,15],
and the use of current inactivated vaccines is limited in
developing countries because of high manufacturing
costs. Increasing G protein expression in RV seed
viruses is hypothesized to improve rabies inactivated
vaccines not only via immunogenicity but also through
increased manufacturing productivity. Previous studies
have demonstrated the feasibility of introducing an addi-
tional G gene into the RV genome [16-18]. By using
reverse genetics technology, Faber et al. generated a
double-G gene recombinant RV (SPBNGA-GA). This
double-G virus showed a 1.6-fold increase in G protein
expression in cell culture relative to that of its single-G
gene parent virus (SPBNGA). Inoculation with
SPBNGA-GA live virus provided more efficient protec-
tive immunity than did the SPBNGA strain in mice.
However, the utility of SPBNGA-GA as a seed virus for
inactivated vaccine production has not been evaluated
further [18]. In another study, Hosokawa-Muto et al.
generated a double-G gene recombinant RV RC-HL.
This virus showed a 1.5-fold increase in G protein
expression in cell culture compared with that induced in
the single-G gene parent virus RC-HL[16]. When the
recombinant double-G gene RC-HL and wild-type RC-
HL were inactivated and used to vaccinated mice, no
significant difference in RV neutralization antibody
responses was observed.
Here, we generated a recombinant LEP virus carrying
an additional G gene, rLEP-G. This recombinant virus
produced strikingly higher levels of G protein in cell
culture and showed similar in vitro growth properties
and bio-safety characteristics. Inactivated vaccine pre-
pared from rLEP-G induced significant higher RV VNA
titers in mice and dogs than those induced by LEP-
derived vaccine, indicating that rLEP-G represents an
improved seed virus candidate for inactivated RV vac-
cine manufacture.
Since G protein is a major contributor to the patho-
genicity of rabies virus [19-22], we evaluated whether
this increase in G protein expression affected the viru-
lence of the rLEP-G virus. We found that the insertion
of this additional G gene results in increase of G protein
expression but not in increase of the neuro-invasiveness
or peripheral pathogenicity of the virus in adult mice. In
other studies, introduction of one or two additional G
genes into the genome of rabies virus resulted in a
higher level of G protein expression and attenuate
pathogenicity in adult mice [17,18,23]. As the pathogeni-
city of a particular RV strain correlates inversely with its
ability to trigger apoptosis in neuron cells[23], one pos-
sible explanation for this discrepancy is that some lethal
viruses, such as LEP and rLEP-G, rarely induced apopto-
sis in neuron cells. In fact, our previous data had shown
that there was no clear correlation between apoptosis
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expression level among LEP and its relative mutants or
chimerical viruses[19].
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